Trinity Biotech (TRIB) Research & Development (2009 - 2024)
Trinity Biotech (TRIB) posted Research & Development of -$1.5 million for Q4 2024, down 43.86% sequentially from -$1.0 million in Q3 2024, and down 30.08% YoY from -$2.1 million in Q1 2024.
Trinity Biotech (TRIB) Research & Development (2009 - 2024) Analysis & Trends
Trinity Biotech has reported Research & Development for 16 years, with the latest figure at -$1.5 million in Q4 2024.
- Quarterly Research & Development fell 30.08% year-over-year to -$1.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$4.5 million (down 3.75% YoY) and the FY2025 annual result came in at $3.6 million, down 20.12% from the prior year.
- Research & Development slipped to -$1.5 million in Q4 2024 per TRIB's latest filing, from -$1.0 million in the prior quarter.
- Over five years, Research & Development peaked at -$860000.0 in Q1 2023 and troughed at -$1.5 million in Q4 2024.
- A 5-year average of -$1.1 million and a median of -$1.1 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2024: Research & Development surged 32.85% in 2022, then sank 30.08% in 2024.
- Over 5 years, Research & Development stood at -$1.3 million in 2020, then climbed by 26.71% to -$941000.0 in 2021, then retreated by 23.91% to -$1.2 million in 2022, then grew by 4.2% to -$1.1 million in 2023, then tumbled by 30.08% to -$1.5 million in 2024.
- According to Business Quant data, Research & Development over the past three periods registered -$1.5 million, -$1.0 million, and -$991000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Trinity Biotech | 6.45 Mn | 1.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.45 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -991,000.00 |
| Mar 31, 2024 | -1.09 Mn |
| Dec 31, 2023 | -1.12 Mn |
| Sep 30, 2023 | -1.17 Mn |
| Jun 30, 2023 | -1.23 Mn |
| Mar 31, 2023 | -860,000.00 |
| Dec 31, 2022 | -1.17 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -984,000.00 |
| Mar 31, 2022 | -965,000.00 |
| Dec 31, 2021 | -941,000.00 |
| Sep 30, 2021 | -1.06 Mn |
| Jun 30, 2021 | -1.06 Mn |
| Mar 31, 2021 | -1.44 Mn |
| Dec 31, 2020 | -1.28 Mn |
| Sep 30, 2020 | -1.27 Mn |
| Jun 30, 2020 | -1.15 Mn |
| Mar 31, 2020 | -1.38 Mn |